🇺🇸 fluticasone propionate hydrofluoroalkane (HFA) in United States

FDA authorised fluticasone propionate hydrofluoroalkane (HFA) on 14 May 2004

Marketing authorisations

FDA — authorised 14 May 2004

  • Application: NDA021433
  • Marketing authorisation holder: GLAXO GRP LTD
  • Local brand name: FLOVENT HFA
  • Indication: AEROSOL, METERED — INHALATION
  • Status: approved

Read official source →

FDA

  • Status: approved

fluticasone propionate hydrofluoroalkane (HFA) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is fluticasone propionate hydrofluoroalkane (HFA) approved in United States?

Yes. FDA authorised it on 14 May 2004; FDA has authorised it.

Who is the marketing authorisation holder for fluticasone propionate hydrofluoroalkane (HFA) in United States?

GLAXO GRP LTD holds the US marketing authorisation.